Join BTG Vascular at a
Congress near you and learn about our diverse product portfolio.

EVENTS

29 Aug APPLE

All Events

CORPORATE AND REGIONAL PRESS RELEASES

19 Aug BOSTON SCIENTIFIC CLOSES ACQUISITION OF ...

29 Apr Venous Leg Ulcer Registry Shows Promisin...

07 Nov BTG Sentry Bioconvertible IVC Filter 2-y...

All Press Releases

Information Information

About BTG

About Vascular

Vascular Products

  1. Parikh, S., et al., J Vasc Interv Radiol, Vol. 19, Issue 4, April 2008, 521–528.
  2. Litzendorf, M., et al., SVS 2011 Abstract RR20.
  3. Schrijver, A.M., et al., J.Endovasc Therapy 2015;22(1):87-95.
  4. Kucher, N., et al., Circulation, Vol. 129, No. 4, 2014, 479–486.
  5. Piazza, G., et al., JACC: Cardiovasc Intervent 2015; 8(10): 1382-92.
  6. Heit JA et.al., Abstract #910; 2005:106 (no.11) part 1 of 2, pg. 267a.
  7. Gerotziafas et.al., Curr Opin Pulm Med. 2004;10:356-65.
  8. Banovac, R et al., J Vasc Interv Radiol, 2010; 21:44-53.
  9. Soltani, A et al. Ultrasonics 2007; 46:60-67.
  10. Kahn, S et al. Arch Intern Med 2004; 164:17-26.
  11. Ashrani AA, Heit JA. J Thromb Thrombolysis. 2009;28::465-476.
  12. Kahn, S. et al., Annals of Internal Medicine, 149, 2008, 698–707.
  13. Patel M.S. et al. J Vasc Interv Radiol 2012; 23(3):S119.
  14. Lin, P., et al., Vasc, Vol. 17, Suppl. 3, 2009, S137-S147.
  15. Lin., P., et al., Perspectives in Vasc Surg and Endo Ther, 2010, 22(3):152-163.
  16. Francis, C.W., et al., Ultrasound in Medicine and Biology, 21.3, 1995, 419–424.
  17. Nykamp, M., et al., Journal of Vascular Surgery:  Venous and Lymphatic Disorders 2015;3(5):251-257.
  18. Braaten, J.V, et al., Ultrasound Reversibly Disaggegates Fibrin Fibers, Throm Haemost, 1997, 78:1063-8
  19. Tapson, Victor, et al., “A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.” JACC: Cardiovascular Interventions Jul 2018, 11 (14) 1401-1410.

Click here for product indications and contraindications

© 2018 BTG International Ltd. All rights reserved. “Imagine where we can go.”, BTG and the BTG roundel logo are trademarks and/or registered trademarks of BTG International Ltd. Bead Block, DC Bead, DC BeadM1, DC Bead LUMI, LC Bead, LC BeadM1, LC Bead LUMI, LUMI, Simplicit90Y, IO Loop and IO Ablation are trademarks and/or registered trademarks of Biocompatibles UK Ltd. EKOS is a trademark and/or registered trademark of EKOS Corporation. GALIL, ICEROD, iTHAW, ICESPHERE, ICESEED, IceEDGE, VISUAL-ICE, ICEORCE, ICEPEARL, ICEFX are trademarks and/or registered trademarks of Galil Medical Ltd. PneumRx is a trademark and/or registered trademark of PneumRx, Inc. TheraSphere is a trademark and/or registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd. Varithena is a trademark and/or registered trademark of Provensis Ltd. CroFab and DigiFab are trademarks and/or registered trademarks of BTG International, Inc. Voraxaze is a trademark and/or registered trademark of Protherics Medicines Development Ltd. SnakeBite911 and the SnakeBite911 logo are trademarks and/or registered trademarks of Protherics UK Ltd. MicroCross, CenterCross and MultiCross are trademarks and/or registered trademarks of Roxwood Medical, Inc. BTG Sentry is a trademark and/or registered trademark of Novate Medical Limited. Lemtrada is a trademark and/or registered trademark of Genzyme Corporation. Zytiga is a trademark and/or registered trademark of Johnson & Johnson. Biocompatibles UK Ltd, EKOS Corporation, Galil Medical Ltd, Novate Medical Limited, PneumRx, Inc., Protherics Medicines Development Ltd, Protherics UK Ltd, Provensis Ltd and Roxwood Medical Inc are all BTG International group companies.

For prescribing information, safety information, and/or product information, go to: bead-block | crofab | dcbead | dcbeadlumi | digifab | ekoscorp | galilmedical | lcbead | lcbeadlumi | lemtrada | pneumrx | therasphere | varithena | voraxaze | zytiga

--%>

BTG is now a part of Boston Scientific.

Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com

CONTINUE LEAVE